Thank you to our speakers, sponsors, and delegates who joined us in 2024 for the summit!
If you are interested in the 2025 event, please get in touch at info@hansonwade.com.
The 4th Fc-Mediated Function Summit was Your Gateway to Advancing Therapeutic Frontiers!
Together, we Supercharged FcRn, FcγR, & IgG, & Understood Targets & Biology to Advance Molecular Development, Clinical Utility, & Novel Therapeutic Applications
As 2023 had delivered a second FcRn inhibitor approval, clinically validating the transformative potential of neonatal Fc receptors across autoimmunity and IO, the therapeutic age of blocking FcRn-IgG interactions and optimized Fc-modulation through Fc-engineering strategies in the latest generation of antibody design had truly begum.
VCs, immunology, and inflammation experts at pharma and biotech had shifted from IO to autoimmunity and the ArgenX-Genmab partnership had catalyzed new work in Fc-engineering; the 4th Fc-Mediated Function Summit was an opportunity to evaluate the transformative potential of FcRn over corticosteroids, immunosuppressants, and B-cell depletion. This was the industry sandpit for intense conversations and networking to advance the next IgG, antibody and FcRn-agonist drugs.
See the full 2024 agenda here to discover the insights that were shared.
Key 2024 Highlights:
Targeting FcRn & FcγR Biology:
The secrets of molecular engineering and real-world clinical outcomes were unlocked by focusing on the critical targets - FcRn and FcγR. Attendees gained insights into the intricacies of their biological pathways, and understood how molecular modifications could translate into tangible clinical benefits.
Unrivaled Content:
As the only conference dedicated exclusively to FcRn, this meeting comprehensively covered the landscape. Attendees were immersed in cutting-edge research, the latest advancements, and a holistic understanding of the subject matter. This focus ensured that participants were at the forefront of knowledge and equipped with insights that were not diluted by unrelated topics, setting this summit apart as a beacon of specialized expertise.
Exceptional Networking:
Meaningful connections were forged with a diverse cohort of professionals spanning immunology, antibody engineering, pharmacology, toxicology, and immuno-oncology. The summit provided a unique opportunity to engage with 60+ peers, facilitating cross-disciplinary partnerships and knowledge exchange.
Download the 2024 Program for more information on:
-
- 17+ Fc-Therapeutic Industry Expert Speakers
- 17+ Ground-breaking Sessions
- 8+ Hours of Industry Networking
- & Much More!
World-Class Speaker Faculty Included:
Exclusive 2024 Speaker Interviews:
Jan Terje Andersen
Professor in Biomedical Innovation | Research Group Leader | CoE Precision Immunotherapy Alliance (PRIMA)
Oslo University | Oslo University Hospital
Companies Attending Included:
Our 2024 Partners:
Other Events in the CNS & Inflammation Series:
